These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34805188)

  • 1. The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines.
    Morais P; Adachi H; Yu YT
    Front Cell Dev Biol; 2021; 9():789427. PubMed ID: 34805188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.
    Zhang L; More KR; Ojha A; Jackson CB; Quinlan BD; Li H; He W; Farzan M; Pardi N; Choe H
    NPJ Vaccines; 2023 Oct; 8(1):156. PubMed ID: 37821446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs.
    Suzuki Y; Ishihara H
    Drug Metab Pharmacokinet; 2021 Dec; 41():100424. PubMed ID: 34757287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
    Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
    Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque.
    Naderi Sohi A; Kiani J; Arefian E; Khosrojerdi A; Fekrirad Z; Ghaemi S; Zim MK; Jalili A; Bostanshirin N; Soleimani M
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases.
    Vadovics M; Muramatsu H; Sárközy A; Pardi N
    Methods Mol Biol; 2024; 2786():167-181. PubMed ID: 38814394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses.
    Hein S; Herrlein ML; Mhedhbi I; Bender D; Haberger V; Benz N; Eisert J; Stingl J; Dreher M; Oberle D; Schulze J; Mache C; Budt M; Hildt C; Wolff T; Hildt E
    Allergy; 2022 Jul; 77(7):2080-2089. PubMed ID: 34820854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech.
    Bekbolsynov D; Waack A; Buskey C; Bhadkamkar S; Rengel K; Petersen W; Brown ML; Sparkle T; Kaw D; Syed FJ; Chattopadhyay S; Chakravarti R; Khuder S; Mierzejewska B; Rees M; Stepkowski S
    Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA vaccines against COVID-19: a showcase for the importance of microbial biotechnology.
    Brüssow H
    Microb Biotechnol; 2022 Jan; 15(1):135-148. PubMed ID: 34788497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMINARTY vaccine (Pfizer/BioNTech).
    Andries J; Viranaicken W; Cordonin C; Herrscher C; Planesse C; Roquebert B; Lagrange-Xelot M; El-Kalamouni C; Meilhac O; Mavingui P; Couret D; Gadea G; Despres P
    Sci Rep; 2022 Apr; 12(1):5999. PubMed ID: 35397679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
    Speich B; Chammartin F; Smith D; Stoeckle MP; Amico P; Eichenberger AL; Hasse B; Schuurmans MM; Müller T; Tamm M; Dickenmann M; Abela IA; Trkola A; Hirsch HH; Manuel O; Cavassini M; Hemkens LG; Briel M; Mueller NJ; Rauch A; Günthard HF; Koller MT; Bucher HC; Kusejko K;
    Trials; 2021 Oct; 22(1):724. PubMed ID: 34674742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions.
    Bakos T; Mészáros T; Kozma GT; Berényi P; Facskó R; Farkas H; Dézsi L; Heirman C; de Koker S; Schiffelers R; Glatter KA; Radovits T; Szénási G; Szebeni J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
    Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
    Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination.
    Abdul-Wahab Kadhum A; Rushdi Abdullah A; Mujahid A
    Arch Razi Inst; 2023 Jun; 78(3):1071-1075. PubMed ID: 38028836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: vaccines, efficacy and effects on variants.
    Rudan I; Adeloye D; Sheikh A
    Curr Opin Pulm Med; 2022 May; 28(3):180-191. PubMed ID: 35200162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.